Long-term results of a phase I/II trial of the addition of celecoxib to chemoradiotherapy for locally advanced or recurrent squamous cell carcinoma of the head-and-neck
Crossref DOI link:
Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY
McDonald, Andrew M.
Bonner, James A.
Nabell, Lisle M.
Carroll, William R.
Al-Naief, Nasser Said
Spencer, Sharon A.
Funding for this research was provided by:
Bristol-Myers Squibb (unknown)
unspecified valid from 2016-10-13